Physician profile
Erik Blutinger
NPI 1205222130
$10,140.06
in general payments reported to CMS, 2019-2025
6 companies · $4,123 in 2025
The $4,123 reported for 2025 was more than what 98% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $18.65 · 2022: $4,422 · 2023: $1,050 · 2024: $526 · 2025: $4,123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,348 · Food and Beverage: $351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,347.96 |
| Food and Beverage | $351.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rivanna Medical, INC | $9,769.98 | 2022-2025 | Accuro, Accuro |
| Astrazeneca Pharmaceuticals LP | $198.82 | 2024 | |
| Janssen Pharmaceuticals, INC | $68.98 | 2020-2023 | Xarelto |
| Fresenius Kabi USA, LLC | $53.88 | 2024 | Dilaudid |
| Pfizer INC. | $24.66 | 2025 | |
| Grifols USA, LLC | $23.74 | 2024 | Hyperrab |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erik Blutinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.